14
Jun

Gene therapy 2.0 at bluebird bio is demonstrating some early signs of success with an upgrade to its experimental therapy for the genetic blood disorder beta-thalassemia demonstrating promising results in a pair of patients, weaning them off the regular blood transfusions needed to stay alive.

…read more

Source: Bluebird’s gene therapy 2.0 weans beta-thalassemia patients off blood transfusions

    

0 No comments